Literature DB >> 7860450

Combined pharmacotherapy: an emerging trend in pediatric psychopharmacology.

T E Wilens1, T Spencer, J Biederman, J Wozniak, D Connor.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 7860450     DOI： 10.1097/00004583-199501000-00021

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN： 0890-8567            Impact factor:   8.829


× No keyword cloud information.
  15 in total

1.  Prenatal alcohol exposure and sleep-wake behaviors: exploratory and naturalistic observations in the clinical setting and in an animal model.

Authors:  Osman S Ipsiroglu; Katarina Wind; Yi-Hsuan Amy Hung; Mai Berger; Forson Chan; Wayne Yu; Sylvia Stockler; Joanne Weinberg
Journal:  Sleep Med       Date:  2018-10-25       Impact factor: 3.492

2.  Trends in psychotropic polypharmacy among youths enrolled in Ohio Medicaid, 2002-2008.

Authors:  Cynthia A Fontanella; Lynn A Warner; Gary S Phillips; Jeffrey A Bridge; John V Campo
Journal:  Psychiatr Serv       Date:  2014-10-31       Impact factor: 3.084

3.  Onset of abnormal movements and cardiovascular symptoms after acute change in complex polypharmacy in a child with attention-deficit/hyperactivity disorder and mood symptoms.

Authors:  Presenters Ornella Potter; Nadyah John; Discussant Barbara J Coffey
Journal:  J Child Adolesc Psychopharmacol       Date:  2012-10       Impact factor: 2.576

Review 4.  Safety issues in the use of methylphenidate. An American perspective.

Authors:  M D Rappley
Journal:  Drug Saf       Date:  1997-09       Impact factor: 5.606

5.  Population pharmacokinetic/pharmacodynamic modeling of guanfacine effects on QTc and heart rate in pediatric patients.

Authors:  William Knebel; James Ermer; Jaideep Purkayastha; Patrick Martin; Marc R Gastonguay
Journal:  AAPS J       Date:  2014-08-19       Impact factor: 4.009

6.  The extent of drug therapy for attention deficit-hyperactivity disorder among children in public schools.

Authors:  G B LeFever; K V Dawson; A L Morrow
Journal:  Am J Public Health       Date:  1999-09       Impact factor: 9.308

7.  Prescribing patterns for treatment of pediatric bipolar disorder in a specialty clinic.

Authors:  Mona P Potter; Howard Y Liu; Michael C Monuteaux; Carly S Henderson; Janet Wozniak; Timothy E Wilens; Joseph Biederman
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-10       Impact factor: 2.576

8.  An open study of adjunct OROS-methylphenidate in children and adolescents who are atomoxetine partial responders: I. Effectiveness.

Authors:  Timothy E Wilens; Paul Hammerness; Linsey Utzinger; Mary Schillinger; Anna Georgiopoulous; Robert L Doyle; Marykate Martelon; Kerry Brodziak
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-10       Impact factor: 2.576

9.  Interactions of attention-deficit/hyperactivity disorder therapeutic agents with the efflux transporter P-glycoprotein.

Authors:  Hao-Jie Zhu; Jun-Sheng Wang; Jennifer L Donovan; Yan Jiang; Bryan B Gibson; C Lindsay DeVane; John S Markowitz
Journal:  Eur J Pharmacol       Date:  2007-10-05       Impact factor: 4.432

10.  Disparities in identification of comorbid diagnoses in children with ADHD.

Authors:  Tanjala T Gipson; Eboni I Lance; Rebecca A Albury; Maura B Gentner; Mary L Leppert
Journal:  Clin Pediatr (Phila)       Date:  2014-10-10       Impact factor: 1.168
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.